The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
OS analysis of patients with different short-term response and progression patterns of donafenib versus sorafenib as first-line therapy for advanced hepatocellular carcinoma: An exploratory subgroup analysis of ZGDH3.
 
Shukui Qin
No Relationships to Disclose
 
Feng Bi
No Relationships to Disclose
 
Jianming Xu
No Relationships to Disclose
 
Chengyou Du
No Relationships to Disclose
 
Qingxia Fan
No Relationships to Disclose
 
Longzhen Zhang
No Relationships to Disclose
 
Min Tao
No Relationships to Disclose
 
Da Jiang
No Relationships to Disclose
 
Senming Wang
No Relationships to Disclose
 
Yongping Chen
No Relationships to Disclose
 
Jifang Sheng
No Relationships to Disclose
 
Xuelong Zhuang
No Relationships to Disclose
 
Jun Wu
No Relationships to Disclose